Quentin Bazot

445 total citations
16 papers, 343 citations indexed

About

Quentin Bazot is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Quentin Bazot has authored 16 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 7 papers in Molecular Biology and 6 papers in Epidemiology. Recurrent topics in Quentin Bazot's work include Viral-associated cancers and disorders (13 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (3 papers). Quentin Bazot is often cited by papers focused on Viral-associated cancers and disorders (13 papers), Cytomegalovirus and herpesvirus research (5 papers) and HIV Research and Treatment (3 papers). Quentin Bazot collaborates with scholars based in United Kingdom, France and Germany. Quentin Bazot's co-authors include Martin J. Allday, Robert E. White, Kostas Paschos, Gillian A. Parker, Jens Kalchschmidt, Christine T. Styles, Évelyne Manet, Vincent Lotteau, Henri Gruffat and Lionel Tafforeau and has published in prestigious journals such as Nucleic Acids Research, Journal of Virology and Philosophical Transactions of the Royal Society B Biological Sciences.

In The Last Decade

Quentin Bazot

15 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Quentin Bazot United Kingdom 11 258 120 117 107 92 16 343
Jason P. Tourigny United States 5 222 0.9× 79 0.7× 120 1.0× 83 0.8× 85 0.9× 11 305
Richard D. Palermo United Kingdom 9 208 0.8× 92 0.8× 77 0.7× 68 0.6× 134 1.5× 9 327
Olaf Klinke Germany 6 264 1.0× 105 0.9× 88 0.8× 88 0.8× 52 0.6× 8 316
Alexander Buschle Germany 8 256 1.0× 92 0.8× 118 1.0× 123 1.1× 122 1.3× 8 390
Q Zhang United States 5 347 1.3× 100 0.8× 97 0.8× 80 0.7× 121 1.3× 8 403
Jens Kalchschmidt United Kingdom 7 149 0.6× 62 0.5× 60 0.5× 100 0.9× 85 0.9× 8 268
Katherine Fries United States 4 255 1.0× 95 0.8× 70 0.6× 88 0.8× 74 0.8× 5 328
Coral K. Wille United States 10 217 0.8× 57 0.5× 82 0.7× 50 0.5× 134 1.5× 12 332
Christopher M. Yan United States 7 181 0.7× 51 0.4× 103 0.9× 75 0.7× 176 1.9× 9 357
Samantha Correia United Kingdom 6 334 1.3× 178 1.5× 125 1.1× 64 0.6× 41 0.4× 8 386

Countries citing papers authored by Quentin Bazot

Since Specialization
Citations

This map shows the geographic impact of Quentin Bazot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Quentin Bazot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Quentin Bazot more than expected).

Fields of papers citing papers by Quentin Bazot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Quentin Bazot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Quentin Bazot. The network helps show where Quentin Bazot may publish in the future.

Co-authorship network of co-authors of Quentin Bazot

This figure shows the co-authorship network connecting the top 25 collaborators of Quentin Bazot. A scholar is included among the top collaborators of Quentin Bazot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Quentin Bazot. Quentin Bazot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bazot, Quentin, Mohamed El Sayed, Lily Li, et al.. (2025). The manufacture of AAV for gene therapy applications using a closed, semi-automated hollow-fiber bioreactor. Molecular Therapy — Methods & Clinical Development. 33(2). 101496–101496.
2.
Laroudie, Nicolas & Quentin Bazot. (2024). Advancing gene therapy development with a multi-serotype AAV affinity resin. Cell and Gene Therapy Insights. 10(2). 237–253. 1 indexed citations
3.
Paschos, Kostas, Quentin Bazot, Jonathan Lees, Paul J. Farrell, & Martin J. Allday. (2019). Requirement for PRC1 subunit BMI1 in host gene activation by Epstein–Barr virus protein EBNA3C. Nucleic Acids Research. 47(6). 2807–2821. 3 indexed citations
4.
Ortega‐Prieto, Ana Maria, et al.. (2019). Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection. Philosophical Transactions of the Royal Society B Biological Sciences. 374(1773). 20180292–20180292. 13 indexed citations
6.
Bazot, Quentin, Kostas Paschos, & Martin J. Allday. (2018). Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the STK39 Gene in B Cells Infected by EBV. Journal of Virology. 92(7). 12 indexed citations
7.
Styles, Christine T., Quentin Bazot, Gillian A. Parker, et al.. (2017). EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. PLoS Biology. 15(8). e2001992–e2001992. 50 indexed citations
8.
Price, Alexander M., Joanne Dai, Quentin Bazot, et al.. (2017). Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection. eLife. 6. 56 indexed citations
9.
Kalchschmidt, Jens, et al.. (2016). EBNA3C Directs Recruitment of RBPJ (CBF1) to Chromatin during the Process of Gene Repression in EBV Infected B Cells. PLoS Pathogens. 12(1). e1005383–e1005383. 22 indexed citations
10.
Paschos, Kostas, Quentin Bazot, Gillian A. Parker, et al.. (2016). Core binding factor (CBF) is required for Epstein-Barr virus EBNA3 proteins to regulate target gene expression. Nucleic Acids Research. 45(5). 2368–2383. 17 indexed citations
11.
Deschamps, Thibaut, Quentin Bazot, Ruth MacLeod, et al.. (2016). Epstein–Barr virus nuclear antigen 1 interacts with regulator of chromosome condensation 1 dynamically throughout the cell cycle. Journal of General Virology. 98(2). 251–265. 15 indexed citations
12.
Bazot, Quentin, Kostas Paschos, Lenka Skalska, et al.. (2015). Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2. PLoS Pathogens. 11(7). e1005031–e1005031. 37 indexed citations
13.
Allday, Martin J., Quentin Bazot, & Robert E. White. (2015). The EBNA3 Family: Two Oncoproteins and a Tumour Suppressor that Are Central to the Biology of EBV in B Cells. Current topics in microbiology and immunology. 391. 61–117. 53 indexed citations
14.
Bazot, Quentin, Thibaut Deschamps, Lionel Tafforeau, et al.. (2014). Epstein–Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1. Nucleic Acids Research. 42(15). 9700–9716. 25 indexed citations
16.
Juillard, Franceline, Quentin Bazot, Lionel Tafforeau, et al.. (2012). Epstein–Barr virus protein EB2 stimulates cytoplasmic mRNA accumulation by counteracting the deleterious effects of SRp20 on viral mRNAs. Nucleic Acids Research. 40(14). 6834–6849. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026